V35F (p.Val35Phe) variant of AGT (Angiotensinogen)

V35F (p.Val35Phe) in AGT (Angiotensinogen) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.31 / 1. The record also includes population frequency data and structural context.

V35F (p.Val35Phe) variant details